Pacer Advisors, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Pacer Advisors, Inc.

$41.8 Billion
Q3 2024

A detailed history of Pacer Advisors, Inc. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 25,011 shares of ARWR stock, worth $486,463. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,011

Previous 19,474 28.43%

Holding current value

$486,463

Previous $506,000 4.35%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$19.36 - $29.54 $107,196 - $163,562	5,537 Added 28.43%	25,011 $484,000
Q2 2024 Aug 13, 2024	SELL	$21.87 - $28.24 $10,585 - $13,668	-484 Reduced 2.43%	19,474 $506,000
Q1 2024 May 10, 2024	BUY	$27.21 - $39.48 $104,459 - $151,563	3,839 Added 23.82%	19,958 $570,000
Q4 2023 Jan 16, 2024	BUY	$21.2 - $31.03 $151,580 - $221,864	7,150 Added 79.72%	16,119 $493,000
Q3 2023 Nov 13, 2023	SELL	$26.2 - $36.08 $372,642 - $513,165	-14,223 Reduced 61.33%	8,969 $240,000
Q2 2023 Jul 12, 2023	BUY	$25.16 - $41.38 $369,147 - $607,127	14,672 Added 172.21%	23,192 $827,000
Q1 2023 May 02, 2023	SELL	$23.68 - $38.51 $278,713 - $453,262	-11,770 Reduced 58.01%	8,520 $216,000
Q4 2022 Feb 06, 2023	BUY	$28.0 - $40.56 $246,204 - $356,644	8,793 Added 76.48%	20,290 $822,000
Q3 2022 Oct 18, 2022	BUY	$29.63 - $48.31 $340,656 - $555,420	11,497 New	11,497 $380,000
Q2 2022 Aug 12, 2022	SELL	$27.79 - $50.61 $130,807 - $238,221	-4,707 Closed	0 $0
Q1 2022 Apr 05, 2022	SELL	$39.62 - $69.97 $420,447 - $742,521	-10,612 Reduced 69.27%	4,707 $216,000
Q4 2021 Feb 03, 2022	BUY	$58.09 - $82.51 $48,447 - $68,813	834 Added 5.76%	15,319 $1.02 Million
Q3 2021 Oct 15, 2021	SELL	$58.38 - $84.96 $110,805 - $161,254	-1,898 Reduced 11.59%	14,485 $904,000
Q2 2021 Jul 21, 2021	BUY	$62.15 - $90.32 $264,323 - $384,130	4,253 Added 35.06%	16,383 $1.36 Million
Q1 2021 Apr 05, 2021	SELL	$61.35 - $90.47 $63,251 - $93,274	-1,031 Reduced 7.83%	12,130 $804,000
Q4 2020 Jan 20, 2021	SELL	$43.82 - $85.37 $643,409 - $1.25 Million	-14,683 Reduced 52.73%	13,161 $1.01 Million
Q3 2020 Oct 19, 2020	BUY	$33.21 - $51.27 $924,699 - $1.43 Million	27,844 New	27,844 $1.2 Million
Q1 2020 Apr 23, 2020	SELL	$20.56 - $63.12 $699,204 - $2.15 Million	-34,008 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$28.14 - $73.01 $371,110 - $962,855	13,188 Added 63.34%	34,008 $2.16 Million
Q3 2019 Oct 10, 2019	BUY	$26.26 - $34.86 $546,733 - $725,785	20,820 New	20,820 $587,000
Q4 2018 Feb 13, 2019	SELL	$10.74 - $19.7 $125,700 - $230,568	-11,704 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.0 - $20.3 $163,856 - $237,591	11,704 New	11,704 $224,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.06B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History